MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics

MLTX | NASDAQ
Chart Builder DCF Calculator
$12.77
+$0.22 (+1.75%)
Sep 22, 2026, 12:56 PM ET · Market open
TTM
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Cash & Equivalents
477.91M 298.49M 334.52M 350.74M 306.68M 271.57M 180.43M 375.66M 342.79M 458.44M 451.17M 318.17M 501.79M 50.13M 39.51M 41.2M 92.71M 101.02M 8.04M 1.03M 1.1M 1.17M
Short-Term Investments
59.13M 59.43M 59.45M 29.74M 118.4M 208.56M 267.6M 118.27M 177.01M 88.61M 59.84M 177.81M n/a 12.92M 32.61M 42.25M n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 115.05M n/a 115.04M 115.04M 115.03M
Other Long-Term Assets
1.34M 1.34M 596K 587K 1.7M 1.7M n/a 2.06M 4.13M 6.32M 8.42M n/a n/a n/a n/a n/a -1 -59.26K -1 -29.85K n/a n/a
Receivables
6.56M 5.76M 4.87M 4.02M 3.41M 2.99M 2.84M 2.41M 1.68M 1.5M 1.06M 720.76K 619.77K 378.45K 217.13K 600.54K 557.05K 15M 148.77K n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
n/a 32.96M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
570.04M 396.64M 421.69M 411.22M 455.48M 506.26M 474.29M 512.32M 536.88M 553.59M 514.17M 500.01M 506.37M 66.5M 76.51M 88.54M 98.38M 116.16M 9.64M 1.21M 1.33M 1.46M
Property-Plant & Equipment
2.57M 2.39M 2.14M 2.53M 2.92M 3.3M 3.64M 3.83M 3.87M 4.21M 3.95M 208.94K 254.05K 292.36K 331.97K 52.68K 55.97K 59.26K 45.74K 29.85K n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
3.91M 3.73M 2.74M 3.12M 4.62M 5M 3.64M 5.9M 8M 10.53M 12.37M 208.94K 254.05K 292.36K 331.97K 52.68K 55.97K 115.05M 45.74K 115.04M 115.04M 115.03M
Total Assets
573.95M 400.37M 424.43M 414.34M 460.1M 511.26M 477.93M 518.21M 544.88M 564.12M 526.54M 500.22M 506.62M 66.8M 76.84M 88.59M 98.43M 231.21M 9.68M 116.25M 116.37M 116.49M
Account Payables
17.04M 23.38M n/a 23.82M 14.89M 10.06M 8.68M 10.26M 4.76M 3.09M 1.46M 824.07K 270.75K 510.52K 65.98K 155.53K 246.75K n/a 1.23M n/a n/a n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -213.45K n/a n/a n/a n/a
Short-Term Debt
n/a n/a 1.23M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 15.15M 15M n/a n/a n/a
Other Current Liabilities
n/a 2.2M 40.83M 4.2M 3.23M 2.54M 4.24M 2.92M 1.96M 1.2M 2.78M 2.76M 904.08K 547.89K 1.11M 217.14K 530.71K 182.57M 1.42M 2.06M 90K 60K
Total Current Liabilities
45.39M 46.11M 45.48M 48.37M 27.36M 23.98M 22.46M 20.08M 12.28M 8.91M 9.97M 10.31M 7.13M 7.28M 7.67M 6.02M 3.86M 202.79M 21.09M 2.06M 90K 60K
Long-Term Debt
99.51M 99.88M 74.47M 73.74M 73.38M 73.02M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
74K 353K -374K 549K 574K 536K 620.68K 694.96K 541.95K 462.74K 583.43K 255.4K 323.6K 314.17K 282.21K 4.99K 18.59K 4.03M 239.86K 4.03M 4.03M 4.03M
Total Long-Term Liabilities
100.36M 100.24M 74.47M 74.78M 74.79M 74.7M 2.08M 2.63M 2.56M 2.82M 3.08M 268.48K 376.61K 405.26K 411.16K 4.99K 18.59K 4.03M 239.86K 4.03M 4.03M 4.03M
Total Liabilities
145.75M 146.35M 119.95M 123.14M 102.15M 98.68M 24.54M 22.71M 14.85M 11.73M 13.05M 10.58M 7.51M 7.68M 8.08M 6.02M 3.88M 206.82M 21.33M 6.08M 4.12M 4.09M
Total Debt
101.53M 100.8M 75.71M 75.73M 75.77M 75.6M 2.83M 3.69M 3.34M 3.66M 3.7M 169.42K 211.24K 246.25K 282.58K n/a n/a 15.15M 15M n/a n/a n/a
Book Value
428.2M 254.02M 304.48M 291.19M 357.94M 412.58M 453.39M 495.5M 530.03M 552.39M 513.49M 489.64M 499.11M 59.11M 68.77M 82.57M 94.56M 24.4M -11.65M 110.16M 112.26M 112.41M
Book Value Per Share
5.79 3.56 4.72 4.60 5.66 6.52 7.19 7.88 8.43 8.82 8.57 9.15 11.42 1.51 1.77 2.24 2.69 0.66 -0.32 2.98 3.04 7.59
Common Stock
8K 7K 7K 6K 6K 6K 6.39K 6.39K 6.39K 6.39K 6.3K 6.25K 6.25K 5.27K 5.27K 5.27K 5.27K 673 38.54K 115M 107.26M 107.41M
Retained Earnings
-594.42M -532.62M -462.91M -400.49M -330.76M -275.54M -235.59M -189.99M -154.6M -130.33M -116.66M -109.22M -99.79M -89.66M -80.65M -68.79M -58.68M -9.76M -53.64M -4.84M -319.46K -167.13K
Comprehensive Income
630K 322K 604K 278K 520K 2.39M 5M 2.83M 3.26M 2.69M 2.36M 2.88M 35.12K 340.11K 350.95K 245.28K 133.72K 98.09K -168.18K 0 n/a n/a
Shareholders Equity
428.2M 254.02M 304.48M 288.91M 353.73M 407.52M 446.83M 488.2M 520.66M 542.55M 495.68M 424.93M 489.8M 42M 48.9M 55.29M 63.51M 24.4M -11.65M 110.16M 112.26M 112.41M
Total Investments
59.13M 59.43M 59.45M 29.74M 118.4M 208.56M 267.6M 118.27M 177.01M 88.61M 59.84M 177.81M n/a 12.92M 32.61M 42.25M n/a 115.05M n/a 115.04M 115.04M 115.03M

© 2026 bestshares.com. All rights reserved.